This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Verdecchia, P. Articles by Porcellati, C. Search for Related Content PubMed PubMed Citation Articles by Verdecchia, P. Articles by Porcellati, C. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure

(Hypertension. 1997;29:1218-1224.)
© 1997 American Heart Association, Inc.

Articles

Prognostic Significance of the White Coat Effect

Paolo Verdecchia; Giuseppe Schillaci; Claudia Borgioni; Antonella Ciucci; ; Carlo Porcellati

From Ospedale Generale Regionale Raffaello Silvestrini, Area Omogenea di Cardiologia e Medicina, Perugia, and Ospedale Beato G. Villa, Città della Pieve (G.S.), Italy.

Abstract The difference between clinic and ambulatory blood pressure (BP) has been used to quantify the pressure reactivity to the doctor's visit (white coat effect). We investigated the prognostic significance of the clinic-ambulatory BP difference in the setting of the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA) study. A total of 1522 subjects contributed 6371 person-years of observation. All subjects had an initial off-therapy diagnostic workup including 24-hour noninvasive ambulatory BP monitoring. The predicted values of ambulatory BP progressively diverged from the identity line (white coat effect of 0 mm Hg) with increasing clinic BP, but the predicted values of clinic BP tended toward the identity line with increasing ambulatory BP. Hence, the clinic-ambulatory BP difference showed a direct association with clinic BP and an inverse association with ambulatory BP. Consequently, a high clinic-ambulatory BP difference predicted both a high clinic and a low ambulatory BP, whereas a low clinic-ambulatory BP difference predicted both a low clinic and a high ambulatory BP. The clinic-ambulatory BP difference showed also a direct association with age. During up to 9 years of follow-up (mean, 4.2 years), there were 157 major cardiovascular morbid events (125 nonfatal and 32 fatal). The rate of total cardiovascular morbid events did not differ (log-rank test) among the four quartiles of the distribution of the clinic-ambulatory BP difference (2.13, 2.92, 2.10, and 2.83 events per 100 patient-years for systolic BP and 2.94, 2.14, 2.58, and 2.16 events per 100 patient-years for diastolic BP). Also, the rate of fatal cardiovascular events did not differ among the four quartiles of the distribution of the clinic-ambulatory BP difference. The clinic-ambulatory BP difference, taken as a measure of the white coat effect, does not predict cardiovascular morbidity and mortality in subjects with essential hypertension.

Key Words: prognosis • blood pressure monitoring, ambulatory • hypertension, white coat

This article has been cited by other articles:

				G. Mancia, M. Bombelli, R. Facchetti, F. Madotto, F. Quarti-Trevano, H. P. Friz, G. Grassi, and R. Sega Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension Hypertension, August 1, 2009; 54(2): 226 - 232. [Abstract] [Full Text] [PDF]

				J. D. Spence White-Coat Hypertension Is Hypertension Hypertension, May 1, 2008; 51(5): 1272 - 1272. [Full Text] [PDF]

				G. Mancia, R. Facchetti, M. Bombelli, G. Grassi, and R. Sega Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure Hypertension, May 1, 2006; 47(5): 846 - 853. [Abstract] [Full Text] [PDF]

				J. N. Cohn, A. A. Quyyumi, N. K. Hollenberg, and K. A. Jamerson Surrogate Markers for Cardiovascular Disease: Functional Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-31 - IV-46. [Full Text] [PDF]

				F. A. Augustovski, C. B. Calvo, M. Deprati, and G. Waisman The Deep-Breath Test as a Diagnostic Maneuver for White-Coat Effect in Hypertensive Patients J Am Board Fam Med, May 1, 2004; 17(3): 184 - 189. [Abstract] [Full Text] [PDF]

				P. Verdecchia, F. Angeli, and R. Gattobigio Clinical Usefulness of Ambulatory Blood Pressure Monitoring J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S30 - 33. [Abstract] [Full Text]

				G. Mancia and G. Parati Ambulatory Blood Pressure Monitoring and Organ Damage Hypertension, November 1, 2000; 36(5): 894 - 900. [Abstract] [Full Text] [PDF]

				J. A Staessen, E. T O'Brien, L. Thijs, and R. H Fagard Modern approaches to blood pressure measurement Occup. Environ. Med., August 1, 2000; 57(8): 510 - 520. [Abstract] [Full Text]

				C D A Goonasekera and M J Dillon Current topic: Measurement and interpretation of blood pressure Arch. Dis. Child., March 1, 2000; 82(3): 261 - 265. [Full Text]

				P. Verdecchia Prognostic Value of Ambulatory Blood Pressure : Current Evidence and Clinical Implications Hypertension, March 1, 2000; 35(3): 844 - 851. [Abstract] [Full Text] [PDF]

				G. Parati, L. Ulian, L. Sampieri, P. Palatini, A. Villani, A. Vanasia, and G. Mancia Attenuation of the "White-Coat Effect" by Antihypertensive Treatment and Regression of Target Organ Damage Hypertension, February 1, 2000; 35(2): 614 - 620. [Abstract] [Full Text] [PDF]

				J. A. Staessen, L. Thijs, R. Fagard, E. T. O'Brien, D. Clement, P. W. de Leeuw, G. Mancia, C. Nachev, P. Palatini, G. Parati, et al. Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension JAMA, August 11, 1999; 282(6): 539 - 546. [Abstract] [Full Text] [PDF]

				M. B. MacDonald, G. P. Laing, M. P. Wilson, and T. W. Wilson Prevalence and predictors of white-coat response in patients with treated hypertension Can. Med. Assoc. J., August 1, 1999; 161(3): 265 - 269. [Abstract] [Full Text] [PDF]

				J. D. Spence Withholding treatment in white-coat hypertension: wishful thinking Can. Med. Assoc. J., August 1, 1999; 161(3): 275 - 276. [Full Text] [PDF]

				P. Lantelme, H. Milon, C. Gharib, C. Gayet, and J.-O. Fortrat White Coat Effect and Reactivity to Stress : Cardiovascular and Autonomic Nervous System Responses Hypertension, April 1, 1998; 31(4): 1021 - 1029. [Abstract] [Full Text] [PDF]

				S. D. Pierdomenico, F. Costantini, A. Bucci, D. De Cesare, F. Cuccurullo, and A. Mezzetti Low-Density Lipoprotein Oxidation and Vitamins E and C in Sustained and White-Coat Hypertension Hypertension, February 1, 1998; 31(2): 621 - 626. [Abstract] [Full Text] [PDF]

				J. A. Staessen, G. Byttebier, F. Buntinx, H. Celis, E. T. O'Brien, and R. Fagard Antihypertensive Treatment Based on Conventional or Ambulatory Blood Pressure Measurement: A Randomized Controlled Trial JAMA, October 1, 1997; 278(13): 1065 - 1072. [Abstract] [PDF]